Evidence map›Paper›PMID 40375910›Full record

ArticleMediterranean journal of hematology and infectious diseases2025

Long-term Persistence of Dysplastic Features in Patients with Acute Promyelocytic Leukemia Treated with All-trans Retinoic Acid and Arsenic Trioxide.

Enrico Santinelli, Maria Rosaria Pascale, Luca Guarnera, Arianna Savi, Flavia Mallegni, Maria Luigia Catanoso, Carmelo Gurnari, Luca Maurillo, Maria Teresa Voso, Susanna Fenu

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Mediterranean journal of hematology and infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Enrico SantinelliDepartment of Biomedicine and Prevention, PhD program in immunology, molecular medicine, and applied biotechnologies, University of Rome Tor Vergata, Rome, 00133, Italy.
Maria Rosaria PascaleDepartment of Biomedicine and Prevention, PhD program in immunology, molecular medicine, and applied biotechnologies, University of Rome Tor Vergata, Rome, 00133, Italy.
Luca GuarneraDepartment of Biomedicine and Prevention, PhD program in immunology, molecular medicine, and applied biotechnologies, University of Rome Tor Vergata, Rome, 00133, Italy.
Arianna SaviDepartment of Clinical and Biological Sciences, University of Turin, 10043 Turin, Italy.
Flavia MallegniDepartment of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, 00133, Italy.
Maria Luigia CatanosoDepartment of Pediatric Hematology/Oncology, Cell and Gene Therapy, Istituto di Ricovero e Cura a Carattere Scientifico Bambino Gesù Children's Hospital, Rome, Italy.
Carmelo GurnariDepartment of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, 00133, Italy.
Luca MaurilloHematology, Fondazione Policlinico Tor Vergata, 00133 Rome, Italy.
Maria Teresa Voso *Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, 00133, Italy.
Susanna Fenu *Haematology Department, San Giovanni-Addolorata Hospital, Rome, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Acute promyelocytic leukemiaArsenic trioxideDysplasia

Identifiers

PMID40375910
PMCPMC12081039

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.